Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone

EU orphan designation number: EU/3/05/279   
Active ingredient: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Centralised Orphan - Designation EMEA/OD/001/05 (2005)1658 of 27/05/2005
23/10/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/001/05/T/01 (2008)6247 of 21/10/2008
01/10/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/001/05/T/02 (2010)6802 of 28/09/2010
30/05/2011 Other procedure EMEA/OD/001/05